Hamps Bio (BOM:544312) Shareholder Yield % : -10.97% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544312 Hamps Bio Ltd BOM:544312
12 GF Score
Price ₹22.50
! 4 Warning Signs
View Full Analysis

What is Hamps Bio Shareholder Yield %?

Hamps Bio BOM:544312 -2.17% 12 Shareholder Yield % is -10.97% as of Mar. 2026. GuruFocus rates BOM:544312 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 648 Healthcare Providers & Services companies, Hamps Bio ranks worse than 81.17% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Hamps Bio's Shareholder Yield % was -10.97%.


Hamps Bio  (BOM:544312) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Hamps Bio Shareholder Yield % Related Terms


Hamps Bio Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Hamps Bio's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamps Bio Shareholder Yield % Chart

Hamps Bio Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Shareholder Yield %
0.00 0.00 0.00 -43.73 -16.24

Hamps Bio Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Shareholder Yield % Get a 7-Day Free Trial 0.00 0.00 -43.73 -12.47 -16.24

Hamps Bio Shareholder Yield % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Hamps Bio's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamps Bio Shareholder Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Hamps Bio's Shareholder Yield % falls into.


BOM:544312
12GF Score
Hamps Bio Ltd BOM:544312
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamps Bio Shareholder Yield % Calculation

Hamps Bio's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+-16.24 %
=-16.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of -10.97% mean?
Hamps Bio (BOM:544312) has a Shareholder Yield % of -10.97% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Hamps Bio and its competitors. According to the industry distribution chart, Hamps Bio ranks #526 out of 648 companies in the Healthcare Providers & Services industry, placing it in the top 81.2%.
Is Hamps Bio's Shareholder Yield % too high?
Hamps Bio's current Shareholder Yield % is -10.97%. Based on the distribution chart, Hamps Bio ranks #526 out of 648 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hamps Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Shareholder Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #526 out of 648 companies for Shareholder Yield %. This places Hamps Bio in the lower half of its industry. The industry median Shareholder Yield % is 0.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.21, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Shareholder Yield % is -10.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Shareholder Yield % of -10.97%. The current Shareholder Yield % is -10.97%. Hamps Bio's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Shareholder Yield % is -10.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamps Bio Business Description

Address Plot no. C1-B-106, Near Mama Bhanja Factory, Bhatpore GIDC, Adajan Dn, Surat, GJ, IND, 394510
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
12GF Score

Get the complete analysis for BOM:544312

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹22.50
Price